Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001400482-14-000017
Filing Date
2014-05-15
Accepted
2014-05-14 19:30:50
Documents
11
Period of Report
2014-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q acucela-20140331xform10q.htm 10-Q 564315
2 SECTION 302 CEO CERTIFICATION acucela-20140331xexhibit311.htm EX-31.1 10597
3 SECTION 302 CFO CERTIFICATION acucela-20140331xexhibit312.htm EX-31.2 10599
4 SECTION 906 CEO CERTIFICATION acucela-20140331xexhibit321.htm EX-32.1 6046
5 SECTION 906 CFO CERTIFICATION acucela-20140331xexhibit322.htm EX-32.2 5945
  Complete submission text file 0001400482-14-000017.txt   3182990

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT acuc-20140331.xml EX-101.INS 363415
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT acuc-20140331.xsd EX-101.SCH 20528
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT acuc-20140331_cal.xml EX-101.CAL 44263
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT acuc-20140331_def.xml EX-101.DEF 108762
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT acuc-20140331_lab.xml EX-101.LAB 300633
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT acuc-20140331_pre.xml EX-101.PRE 182714
Mailing Address 1301 SECOND AVE. SUITE 1900 SEATTLE WA 98101
Business Address 1301 SECOND AVE. SUITE 1900 SEATTLE WA 98101 206-805-8300
ACUCELA INC. (Filer) CIK: 0001400482 (see all company filings)

EIN.: 020592619 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-55133 | Film No.: 14843302
SIC: 2834 Pharmaceutical Preparations